These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 24460940)
1. Bacterial and cell-free production of APP671-726 containing amyloid precursor protein transmembrane and metal-binding domains. Bocharova OV; Urban AS; Nadezhdin KD; Bocharov EV; Arseniev AS Biochemistry (Mosc); 2013 Nov; 78(11):1263-71. PubMed ID: 24460940 [TBL] [Abstract][Full Text] [Related]
2. Cell-free expression of the APP transmembrane fragments with Alzheimer's disease mutations using algal amino acid mixture for structural NMR studies. Bocharova OV; Urban AS; Nadezhdin KD; Bocharov EV; Arseniev AS Protein Expr Purif; 2016 Jul; 123():105-11. PubMed ID: 27071311 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production. Dimitrov M; Alattia JR; Lemmin T; Lehal R; Fligier A; Houacine J; Hussain I; Radtke F; Dal Peraro M; Beher D; Fraering PC Nat Commun; 2013; 4():2246. PubMed ID: 23907250 [TBL] [Abstract][Full Text] [Related]
4. The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators. Botev A; Munter LM; Wenzel R; Richter L; Althoff V; Ismer J; Gerling U; Weise C; Koksch B; Hildebrand PW; Bittl R; Multhaup G Biochemistry; 2011 Feb; 50(5):828-35. PubMed ID: 21186781 [TBL] [Abstract][Full Text] [Related]
5. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. Munter LM; Voigt P; Harmeier A; Kaden D; Gottschalk KE; Weise C; Pipkorn R; Schaefer M; Langosch D; Multhaup G EMBO J; 2007 Mar; 26(6):1702-12. PubMed ID: 17332749 [TBL] [Abstract][Full Text] [Related]
6. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373 [TBL] [Abstract][Full Text] [Related]
7. [Expression and purification of a recombinant transmembrane domain amyloid precursor protein associated with Alzheimer's disease]. Bocharova OV; Nadezhdin KD; Bocharov EV; Arsen'ev AS Bioorg Khim; 2010; 36(1):105-11. PubMed ID: 20386583 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948 [TBL] [Abstract][Full Text] [Related]
9. Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites. Yan Y; Xu TH; Harikumar KG; Miller LJ; Melcher K; Xu HE J Biol Chem; 2017 Sep; 292(38):15826-15837. PubMed ID: 28790170 [TBL] [Abstract][Full Text] [Related]
10. Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer's Disease Pathogenesis. Bocharov EV; Nadezhdin KD; Urban AS; Volynsky PE; Pavlov KV; Efremov RG; Arseniev AS; Bocharova OV ACS Chem Biol; 2019 Jul; 14(7):1573-1582. PubMed ID: 31180641 [TBL] [Abstract][Full Text] [Related]
12. Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment. Nadezhdin KD; Bocharova OV; Bocharov EV; Arseniev AS FEBS Lett; 2012 Jun; 586(12):1687-92. PubMed ID: 22584060 [TBL] [Abstract][Full Text] [Related]
13. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production. Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942 [TBL] [Abstract][Full Text] [Related]
14. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants. Gorman PM; Kim S; Guo M; Melnyk RA; McLaurin J; Fraser PE; Bowie JU; Chakrabartty A BMC Neurosci; 2008 Jan; 9():17. PubMed ID: 18234110 [TBL] [Abstract][Full Text] [Related]
17. Evidence that the amyloid-β protein precursor intracellular domain, AICD, derives from β-secretase-generated C-terminal fragment. Flammang B; Pardossi-Piquard R; Sevalle J; Debayle D; Dabert-Gay AS; Thévenet A; Lauritzen I; Checler F J Alzheimers Dis; 2012; 30(1):145-53. PubMed ID: 22406447 [TBL] [Abstract][Full Text] [Related]
18. Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein. Gralle M; Oliveira CL; Guerreiro LH; McKinstry WJ; Galatis D; Masters CL; Cappai R; Parker MW; Ramos CH; Torriani I; Ferreira ST J Mol Biol; 2006 Mar; 357(2):493-508. PubMed ID: 16436282 [TBL] [Abstract][Full Text] [Related]
19. Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein. Song Y; Hustedt EJ; Brandon S; Sanders CR Biochemistry; 2013 Jul; 52(30):5051-64. PubMed ID: 23865807 [TBL] [Abstract][Full Text] [Related]